Enhanced Oral Bioavailability of Pueraria Flavones by a Novel Solid Self-microemulsifying Drug Delivery System (SMEDDS) Dropping Pills

To improve bioavailability of pueraria flavones (PF), a self-microemulsifying drug delivery system (SMEDDS) dropping pills composed of PF, Crodamol GTCC, Maisine 35-1, Cremophor RH 40, 1,2-propylene glycol and polyethylene glycol 6000 (PEG6000) was developed.Particle size, zeta potential, morphology and in vitro drug release were investigated, respectively.Pharmacokinetics, bioavailability of PF-SMEDDS dropping pills and commercial Yufengningxin dropping pills were also evaluated and compared in rats.Puerarin treated as the representative component of PF was analyzed.Dynamic light scattering showed the ability of PF-SMEDDS dropping pills to form a nanoemulsion droplet size in aqueous media.The type of media showed no significant effects on the release rate of PF.PF-SMEDDS dropping pills were able to improve the in vitro release rate of PF, and the in vitro release of these dropping pills was significantly faster than that of Yufengningxin dropping pills.There was a dramatic difference between the mean value of t 1/2, peak concentration (C max ), the area of concentration-time curve from 0 to 6 h (AUC 0-6 h ) of PF-SMEDDS dropping pills and that of commercial Yufengningxin dropping pills.A pharmacokinetic study showed that the bioavailability of PF was greatly enhanced by PF-SMEDDS dropping pills.The value of C max and relative bioavailability of PF-SMEDDS dropping pills were dramatically improved by an average of 1.69-and 2.36fold compared with that of Yufengningxin dropping pills after gavage administration, respectively.It was concluded that bioavailability of PF was greatly improved and that PF-SMEDDS dropping pills might be an encouraging strategy to enhance the oral bioavailability of PF.